Pioglitazone Versus Berberine for the Treatment of Non-Alcoholic Fatty Liver Disease(NAFLD)Patients with Impaired Glucose Regulation(IGR)or Type 2 Diabetes Mellitus(T2DM)--intermediate results of a randomized,open,controlled clinical trial | |
Hongmei YAN; Mingfeng XIA; Xinxia CHANG; Hua Bian; Qiong XU; Xin GAO; Yinfang TU; Weiping JIA; Wei DENG | |
2010 | |
会议录 | 第六届华夏内分泌大会
![]() |
语种 | 英语 |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4936367 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Hongmei YAN,Mingfeng XIA,Xinxia CHANG,et al. Pioglitazone Versus Berberine for the Treatment of Non-Alcoholic Fatty Liver Disease(NAFLD)Patients with Impaired Glucose Regulation(IGR)or Type 2 Diabetes Mellitus(T2DM)--intermediate results of a randomized,open,controlled clinical trial[C]. 见:. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论